#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4257019	B	Binding affinity to N-terminal GST tagged CNK PH domain (unknown origin) by SPR spectroscopy	Homo sapiens	21		assay format	Patent Bioactivity Data
2.	ALA4257022	B	Competitive inhibition of CNK1 (unknown origin) binding to PIP3 (unknown origin) at 50 uM by SPR spectroscopy	Homo sapiens	19		assay format	Patent Bioactivity Data
3.	ALA4257027	F	Growth inhibition of human NCI-H1993 cells expressing mutant KRAS incubated for 72 hrs by MTS assay	Homo sapiens	18		cell-based format	Patent Bioactivity Data
4.	ALA4257028	F	Growth inhibition of human A549 cells expressing mutant KRAS incubated for 72 hrs by MTS assay	Homo sapiens	18		cell-based format	Patent Bioactivity Data
5.	ALA4257029	F	Growth inhibition of human NCI-H157 cells expressing mutant KRAS incubated for 72 hrs by MTS assay	Homo sapiens	18		cell-based format	Patent Bioactivity Data
6.	ALA4257030	F	Growth inhibition of human HCC515 cells expressing mutant KRAS incubated for 72 hrs by MTS assay	Homo sapiens	18		cell-based format	Patent Bioactivity Data
7.	ALA4257031	F	Growth inhibition of human NCI-H1944 cells expressing mutant KRAS incubated for 72 hrs by MTS assay	Homo sapiens	18		cell-based format	Patent Bioactivity Data
8.	ALA4257032	F	Growth inhibition of human NCI-H1373 cells expressing mutant KRAS incubated for 72 hrs by MTS assay	Homo sapiens	18		cell-based format	Patent Bioactivity Data
9.	ALA4257033	F	Growth inhibition of human HCC44 cells expressing mutant KRAS incubated for 72 hrs by MTS assay	Homo sapiens	18		cell-based format	Patent Bioactivity Data
10.	ALA4257034	F	Growth inhibition of human NCI-H1792 cells expressing mutant KRAS incubated for 72 hrs by MTS assay	Homo sapiens	18		cell-based format	Patent Bioactivity Data
11.	ALA4257035	F	Growth inhibition of human NCI-H23 cells expressing mutant KRAS incubated for 72 hrs by MTS assay	Homo sapiens	18		cell-based format	Patent Bioactivity Data
12.	ALA4257036	F	Growth inhibition of human NCI-H2122 cells expressing mutant KRAS incubated for 72 hrs by MTS assay	Homo sapiens	18		cell-based format	Patent Bioactivity Data
13.	ALA4257037	F	Antiproliferative activity against human NSCLC cells expressing mutant KRAS assessed as inhibition of 2D cell growth incubated for 72 hrs by MTS assay	Homo sapiens	15		cell-based format	Patent Bioactivity Data
14.	ALA4257038	F	Antiproliferative activity against human NSCLC cells expressing mutant KRAS assessed as inhibition of 3D cell growth after 3 days	Homo sapiens	6		cell-based format	Patent Bioactivity Data
15.	ALA4257051	B	Inhibition of CNKSR1 in human NCI-H1573 cells expressing mutant KRAS assessed as reduction in ERK phosphorylation at 3 to 30 uM incubated for 24 hrs	Homo sapiens	1		cell-based format	Patent Bioactivity Data
16.	ALA4257052	B	Inhibition of CNKSR1 in human NCI-H1573 cells expressing mutant KRAS assessed as reduction in EGFR phosphorylation at 3 to 10 uM incubated for 24 hrs	Homo sapiens	1		cell-based format	Patent Bioactivity Data
17.	ALA4257053	B	Inhibition of CNKSR1 in human NCI-H1573 cells expressing mutant KRAS assessed as reduction in EGFR phosphorylation at 30 uM incubated for 24 hrs	Homo sapiens	1		cell-based format	Patent Bioactivity Data
18.	ALA4257054	F	Growth inhibition of human NCI-H1573 cells expressing wild type KRAS incubated for 72 hrs by MTS assay	Homo sapiens	7		cell-based format	Patent Bioactivity Data
19.	ALA4257055	B	Competitive inhibition of CNK1 (unknown origin) binding to PIP3 (unknown origin) by SPR spectroscopy	Homo sapiens	3		assay format	Patent Bioactivity Data
20.	ALA4419273	F	Growth inhibition of human NCI-H1975 cells incubated for 3 days	Homo sapiens	35		cell-based format	Patent Bioactivity Data